Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 519 results found. Search for [ COVID-19 treatment US ]

Results 1 to 21 of 519
BusinessToday.In
November 23, 2020
India Stock Market Highlights Today: IndusInd Bank, followed by Bajaj Finserv, Bajaj Finance, Reliance Industries, ONGC, NTPC and Tata Steelwere among the top gainerz in the Sensex pack. On the other hand, HDFC, Asian Paints, ITC and Bharti Airtel were among the laggards


Reuters
November 22, 2020
The agency said the antibodies are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19


Joe C Mathew
November 21, 2020
The government has amended the Indian Medicine Central Council Regulations, 2016, to introduce formal training in these procedures as part of the curriculum for postgraduate students of shalya (general surgery) and shalakya (diseases of ear, nose, throat, ENT, eye, head, oro-dentistry) specialisations


Associated Press
November 21, 2020
Biden will be sworn in as the oldest president in the US's history, displacing Ronald Reagan, who left the White House in 1989 when he was 77 years and 349 days old


Shailendra Shukla
New Delhi, November 21, 2020
WHO removes Remdesivir from list of COVID-19 medicines The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients. \"The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for Covi...


PTI
November 20, 2020
Khattar said that considering investors' requirement, connecting global value chains and to handhold the investor through proactive facilitation to navigate business plans, the Haryana government has established a new 'foreign cooperation department'


BusinessToday.In
November 19, 2020
India Stock Market Highlights Today: Infosys, HCL Tech, SBI, Airtel, HUL were among the top losers today, while Bajaj twins, Tata Steel, Titan, ONGC, M&M, NTPC were among the top gainers on Sensex pack 


Mansi Jaswal
November 16, 2020
CA exam: Several students are seeking cancellation of the chartered accountancy exam that will begin on November 21, Saturday


PTI
November 15, 2020
Dexamethasone and other steroids are prescribed to treat cytokine storms, they said these drugs can backfire in patients whose immune response is already suppressed


PTI
November 15, 2020
Many Congress leaders, including Abhishek Singhvi and Tarun Gogoi, had also tested positive for COVID-19 earlier. Besides Vice President M Venkaiah Naidu, several Union ministers had also been infected with the novel coronavirus earlier


PTI
November 14, 2020
According to the researchers, children have lower levels of a receptor protein that the coronavirus SARS-CoV-2 needs to invade airway epithelial cells in the lungs


Reuters
November 13, 2020
The study, published in the journal JAMA, noted that none of the 80 patients who took the antidepressant fluvoxamine met the respiratory deterioration criteria -- compared to an 8.3 per cent rate in the 72 patients who took a dummy pill


Associated Press
November 13, 2020
Trump, fresh off his reelection loss to President-elect Joe Biden, remains angry that an announcement about progress in developing a vaccine for the disease came after Election Day


BusinessToday.In
November 13, 2020
Dalal Street today: IndusInd Bank, followed by SBI, L&T, Axis Bank, HDFC twins, Kotak Bank and ICICI Bank were among the top losers today. On the other hand, Asian Paints, Reliance Industries, Titan, Bajaj Finance and Sun Pharma were trading with gains


PB Jayakumar
November 12, 2020
Zydus Cadila's Pegylated Interferon alpha-2b, PegiHep, was originally approved for Hepatitis C and was launched in the Indian market in 2011; it was repurposed for treating moderate COVID-19 patients


Anshula Raj
November 12, 2020
Based on the Phase 2/3 trial results, SII with the help of ICMR will pursue the early availability of this product for India


PTI
November 12, 2020
Zydus Cadila said its Pegylated Interferon alpha-2b, PegiHep, was originally approved for Hepatitis C and was launched in the Indian market in 2011


Reuters
November 11, 2020
The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data


Reuters
November 9, 2020
Remdesivir was developed by US drugmaker Gilead Sciences, which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of treatment


Chitranjan Kumar
November 6, 2020
Cipla Q2 results: India business grew by 17 per cent YoY and 33 per cent QoQ on the back of strong growth across businesses and continued servicing of patients with COVID-19 portfolio


PAGES 1 OF 26  12345